Cancer drug delivery in the nano era: An overview and perspectives
Z Li, S Tan, S Li, Q Shen, K Wang - Oncology reports, 2017 - spandidos-publications.com
Nanomaterials are increasingly used as drug carriers for cancer therapy. Nanomaterials
also appeal to researchers in the areas of cancer diagnosis and biomarker discovery …
also appeal to researchers in the areas of cancer diagnosis and biomarker discovery …
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
VP Torchilin - Nature reviews Drug discovery, 2014 - nature.com
The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the
in vivo effectiveness of drugs is now well established. The development of multifunctional …
in vivo effectiveness of drugs is now well established. The development of multifunctional …
PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery
Abstract Poly (amidoamine) dendrimers (PAMAM) are well-defined, highly branched,
nanoscale macromolecules with numerous active amine groups on the surface. PAMAM …
nanoscale macromolecules with numerous active amine groups on the surface. PAMAM …
Mechanisms of drug release in nanotherapeutic delivery systems
PT Wong, SK Choi - Chemical reviews, 2015 - ACS Publications
Targeted drug delivery refers to an established therapeutic strategy that develops platforms
and nanoscale devices for selective delivery of small drug molecules and therapeutic genes …
and nanoscale devices for selective delivery of small drug molecules and therapeutic genes …
Cationic polymers and their therapeutic potential
SK Samal, M Dash, S Van Vlierberghe… - Chemical Society …, 2012 - pubs.rsc.org
The last decade has witnessed enormous research focused on cationic polymers. Cationic
polymers are the subject of intense research as non-viral gene delivery systems, due to their …
polymers are the subject of intense research as non-viral gene delivery systems, due to their …
Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives
Y Cheng, L Zhao, Y Li, T Xu - Chemical Society Reviews, 2011 - pubs.rsc.org
In the past decade, nanomedicine with its promise of improved therapy and diagnostics has
revolutionized conventional health care and medical technology. Dendrimers and dendrimer …
revolutionized conventional health care and medical technology. Dendrimers and dendrimer …
Dendrimer‐based nanocarriers: a versatile platform for drug delivery
Advances in nanotechnology have had profound impacts on therapeutic delivery, leading to
the development of nanomaterials engineered with large carrying capabilities and targeting …
the development of nanomaterials engineered with large carrying capabilities and targeting …
The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron–doxorubicin conjugates for cancer therapy
W She, K Luo, C Zhang, G Wang, Y Geng, L Li, B He… - Biomaterials, 2013 - Elsevier
Nanoparticles, such as dendritic polymers, are currently investigated as excellent
candidates for drug delivery vehicles. In this study, we report the preparation and …
candidates for drug delivery vehicles. In this study, we report the preparation and …
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
Purpose Methotrexate (MTX) is one of the most widely studied and effective therapeutics
agents available to treat many solid tumors, hematologic malignancies, and autoimmune …
agents available to treat many solid tumors, hematologic malignancies, and autoimmune …
Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation
JA Mills, F Liu, TR Jarrett, NL Fletcher… - Biomaterials …, 2022 - pubs.rsc.org
For decades, nanomedicines have been reported as a potential means to overcome the
limitations of conventional drug delivery systems by reducing side effects, toxicity and the …
limitations of conventional drug delivery systems by reducing side effects, toxicity and the …